Similar Articles
191 Hepatocellular carcinoma-the role of the underlying liver disease in clinical practice
192 Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinoma
193 Cell division cyclin 25C knockdown inhibits hepatocellular carcinoma development by inducing endoplasmic reticulum stress
194 Coexistence of liver abscess, hepatic cystic echinococcosis and hepatocellular carcinoma: A case report
195 Albumin–bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia
196 Perioperative remedial antiviral therapy in hepatitis B virus-related hepatocellular carcinoma resection: How to achieve a better outcome
197 Plexin domain-containing 1 may be a biomarker of poor prognosis in hepatocellular carcinoma patients, may mediate immune evasion
198 Multidisciplinary comprehensive treatment of massive hepatocellular carcinoma with hemorrhage: A case report and review of literature
199 Diagnostic and prognostic performances of GALAD score in staging and 1-year mortality of hepatocellular carcinoma: A prospective study
200 Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA